In partial fulfillment of the requirements for the Doctor of Philosophy degree in the School of Biomedical Sciences, Jacob Harris will present “Pharmacological Induction of the Nrf2 Gene Program via Synthetic Triterpenoids Imparts Resistance of Renal Proximal Tubular Cells to Hypoxia-Reoxygenation” on June 5, 2024, at 11:00 am CST, in EAD 714.
The campus community is welcome to attend, and a private defense with the advisory committee will immediately follow the seminar.
Jacob Harris is a Medical Sciences Research Track candidate under the guidance and supervision of Dr. Robert Mallet, Ph.D., Professor.